Inhibrx Biosciences, Inc.
Inhibrx Biosciences, Inc. (INXB) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 10 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on May 29, 2024 involved a transaction of 40,000 shares valued at $0.
INXB Insider Activity Summary
Who Is Buying INXB Stock?
No significant insider buying has been recorded for INXB in the recent period.
Who Is Selling INXB Stock?
No significant insider selling has been recorded for INXB in the recent period.
Is Inhibrx Biosciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INXB is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
INXB Frequently Asked Questions
Understanding INXB Insider Activity
Insider trading at Inhibrx Biosciences, Inc. (INXB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading INXB stock, having executed 10 transactions in the past 90 days. The most active insider is Brendan P. Eckelman (Executive), who has made 3 transactions totaling $0.
Related Tools
Track Inhibrx Biosciences, Inc. Insider Activity
Get notified when executives and directors at INXB file new Form 4 transactions